Industry Reports
CluePoints Experiences Continued Rapid Growth as Demand for RBx Rises
CluePoints, a leading provider of Risk-Based Study Execution (RBx) and Data Quality Oversight solutions for clinical trials Has announced a progressive outlook of continued and significant global growth and continued investment in people and technology throughout...
Industry Reports
Sterling Pharma Solutions announces acquisition of CiVentiChem in the US
UK-based contract development and manufacturing organisation , Sterling Pharma Solutions, has announced its acquisition of CiVentiChem’s US facility located in Cary, North Carolina, US. The new facility, located close to the Research Triangle Park, will allow...
Industry Reports
Sterling Pharma Solutions acquired by GHO Capital
GHO Capital, the European specialist investor in healthcare has acquired a majority stake in Sterling Pharma Solutions , a specialist in complex and difficult to manufacture APIs. Headquartered in Newcastle upon Tyne, UK, Sterling is a...
Industry Reports
CRF Bracket Grows More in First Quarter Together than Either Company Achieved Alone in 2018
CRF Bracket recently closed its first full quarter as a combined business after CRF Health and Bracket merged in September of 2018. With more than a 20% increase in new clinical trial business, that first quarter...
Industry Reports
‘Japan second fastest pharma growth in 2019’ CPhI Japan report
The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead of CPhI Japan 2019. The trade exhibition (18-20 March, 2019) will open its doors to 20,000...
Industry Reports
Celgene Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
Celgene Corporation reported operating results for the fourth quarter and full year of 2018. For the fourth quarter of 2018, net product sales were $4,036 million, an increase of 16 percent year-over-year. Fourth quarter total revenue increased 16 percent...
Industry Reports
Hitachi Chemical Co. Ltd. to Acquire apceth Biopharma GmbH
apceth Biopharma GmbH, a leading contract manufacturing organization in the field of cell and gene therapy, announces today that Hitachi Chemical Co., Ltd. will enter into an agreement to acquire all shares of apceth Biopharma GmbH. This acquisition is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
